In vivo pharmacokinetic and anticancer studies of hh-n25, a selective inhibitor of topoisomerase i, and hormonal signaling for treating breast cancer

Bashir Lawal, Yu Cheng Kuo, Maryam Rachmawati Sumitra, Alexander T.H. Wu, Hsu Shan Huang

研究成果: 雜誌貢獻文章同行評審

6 引文 斯高帕斯(Scopus)

指紋

深入研究「In vivo pharmacokinetic and anticancer studies of hh-n25, a selective inhibitor of topoisomerase i, and hormonal signaling for treating breast cancer」主題。共同形成了獨特的指紋。

Medicine & Life Sciences